“Assessment of Dapagliflozin Effectiveness As Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”. Academia Journal of Medicine 4, no. 2 (December 30, 2021): 50–54. Accessed November 24, 2024. https://acspublisher.com/journals/index.php/ajm/article/view/18812.